Pharmacoeconomic comparison of insulin glargine and insulin detemir in diabetes mellitus type 2
Second generation insulin analogue - insulin glargine 300 UI/ml (GLA-300) - can provide an effective control of Diabetes Mellitus (DM) with minimal risk of hypoglycemic events and prevent of cardiovascular complications or events (CVS). Pharmacoeconomic comparison of most used insulins - GLA-300 and...
Saved in:
Main Authors: | I. N. Dyakov (Author), S. K. Zyryanov (Author) |
---|---|
Format: | Book |
Published: |
Izdatelstvo OKI,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The pharmacoeconomic comparison of the fixed insulin glargine and lixisenatide combination with insulin degludec family in type 2 diabetes mellitus
by: I. N. Dyakov, et al.
Published: (2021) -
Comparison of Insulin Detemir and Insulin Glargine for Hospitalized Patients on a Basal-Bolus Protocol
by: Sondra Davis, et al.
Published: (2017) -
Cost-Effectiveness of Insulin Glargine and Insulin Detemir in the Basal Regimen for Naïve Insulin Patients with Type 2 Diabetes Mellitus (T2DM) in Malaysia
by: Shafie AA, et al.
Published: (2020) -
Health technology assessement of the fxed combination of insulin glargine 100 UI/ml and lixisenatide in the treatment intensifcation of diabetes mellitus type 2
by: S. К. Zyryanov, et al.
Published: (2019) -
Pharmacoeconomic comparison of the second generation insulin analogs and insulins on their base
by: I. N. Dyakov, et al.
Published: (2021)